A Real-world Study of Inetetamab for First-line Treatment of MBC
A Real-world Study of Inetetamab for First-line Treatment of MBC
Not yet recruiting · NCT05980208 · Registry updated 2023-08-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Real-world Study of Inetetamab for First-line Treatment of MBC | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Not yet recruiting | Not stated | 2023-08-08 | NCT05980208 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hunan Cancer Hospital | 66 |
| Hunan Medical University General Hospital | 1 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||